Illumina, Inc. (ILMN) Competitors & Peers
The 5 largest companies in the same industry as Illumina, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Peer | $694.76 | P/E 36.6RSI 55Cap 258.2 B |
| DHR | Peer | $230.25 | P/E 38.1RSI 54Cap 162.0 B |
| IDXX | Peer | $676.04 | P/E 45.6RSI 71Cap 53.3 B |
| NTRA | Peer | $310.67 | RSI 29Cap 44.5 B |
| A | Peer | $174.76 | P/E 34.5RSI 53Cap 49.4 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- GRALPartner
Grail was spun off from Illumina and utilizes Illumina next-generation sequencing systems for its Galleri tests.
Model-inferred, unverified — treat as a lead, not evidence - PACBCompetitor
PacBio + Illumina compete in long-read + short-read sequencing.
Model-inferred, unverified — treat as a lead, not evidence - ADPTCompetitor
Competes in immune research profiling and next-generation sequencing application segments.
Model-inferred, unverified — treat as a lead, not evidence - MRNASupplier
Moderna uses Illumina sequencing for vaccine + immune-response profiling.
Model-inferred, unverified — treat as a lead, not evidence